Caffeine in Coffee May Slow Aging, Study Suggests
September 9 - 2026
Coffee Geography Magazine
Researchers at Queen Mary University of London have discovered that the world's most popular stimulant activates a primordial energy-sensing pathway tied to DNA repair and stress resistance.
For millions of people, the morning cup of coffee is simply a ticket to wakefulness. But new research suggests caffeine is doing much more than just blocking drowsiness—it might be flipping a 500-million-year-old cellular switch linked to healthier aging.
Scientists from Queen Mary University of London have found that caffeine activates AMPK (AMP-activated protein kinase), an ancient energy sensor that acts like a cellular fuel gauge. This activation appears to trigger critical biological housekeeping processes, including DNA repair, stress resistance, and metabolic balance—all of which are closely tied to how our cells age.
To uncover how caffeine exerts its effects at the microscopic level, the research team—based in the Cellular Ageing and Senescence laboratory at Queen Mary’s Centre for Molecular Cell Biology—turned to a humble but powerful model organism: fission yeast.
Despite being a single-celled organism, fission yeast shares many essential biological features with human cells, making it a widely used stand-in for studying basic cellular biology. In fact, it is sometimes referred to as a "mini-human" due to these striking similarities.
A few years ago, the same research group demonstrated that caffeine could help cells live longer by influencing a growth regulator called TOR (Target of Rapamycin)—a molecular switch that helps cells decide when to grow based on available energy and nutrients. TOR is remarkably ancient, with versions of it regulating growth for over half a billion years.
However, the latest study, published by the team, reveals a surprising twist. Instead of acting directly on TOR, caffeine appears to work through a parallel ancient system: AMPK.
While TOR acts like a growth accelerator, AMPK acts as a diligent fuel gauge. Its primary job is to detect when cellular energy is running low and adjust metabolism to keep the cell alive and functioning.
"When your cells are low on energy, AMPK kicks in to help them cope," explains Dr. Charalampos (Babis) Rallis, the study's senior author. "And our results show that caffeine helps flip that switch."
This distinction is critical because AMPK is a deeply "conserved" pathway—meaning it has survived through evolution because it performs an essential job. It is found in both yeast and humans, making it a prime target for researchers studying aging, metabolism, and disease.
The discovery positions caffeine alongside some of the most talked-about compounds in longevity research. AMPK is the same pathway activated by metformin, a widely used diabetes drug that is currently being investigated for its potential anti-aging effects. It also overlaps with the signaling influenced by rapamycin, another compound studied for its lifespan-extending properties.
By activating this ancient switch, caffeine influences not just energy balance, but also the cell's ability to repair genetic damage. As we age, DNA damage accumulates. If cells fail to repair this damage efficiently, normal function declines and the risk of age-related diseases rises.
"These findings help explain why caffeine might be beneficial for health and longevity," said Dr. John-Patrick Alao, the postdoctoral research scientist leading the study. "And they open up exciting possibilities for future research into how we might trigger these effects more directly—with diet, lifestyle, or new medicines."
This confirms that caffeine is not merely a neurostimulant, but a bioactive compound capable of speaking to our cells' most fundamental survival systems.
Understanding precisely how caffeine taps into this ancient energy network could pave the way for novel therapies that mimic its beneficial effects on aging—without the inevitable jitters.









